Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Viatris Inc (VTRS)

Viatris Inc (VTRS)
7.11 -0.68 (-8.73%) 14:12 ET [NASDAQ]
7.10 x 423 7.11 x 204
Realtime by (Cboe BZX)
7.10 x 423 7.11 x 204
Realtime 7.63 -0.16 (-2.05%) 09:28 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.13
Day High
7.61
Open 7.59
Previous Close 7.79 7.79
Volume 11,621,263 11,621,263
Avg Vol 16,469,012 16,469,012
Stochastic %K 16.71% 16.71%
Weighted Alpha -48.18 -48.18
5-Day Change -1.10 (-13.48%) -1.10 (-13.48%)
52-Week Range 6.85 - 13.55 6.85 - 13.55
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,298,837
  • Shares Outstanding, K 1,193,689
  • Annual Sales, $ 14,739 M
  • Annual Income, $ -634,200 K
  • EBIT $ 10 M
  • EBITDA $ 2,903 M
  • 60-Month Beta 0.91
  • Price/Sales 0.60
  • Price/Cash Flow 1.44
  • Price/Book 0.47

Options Overview Details

View History
  • Implied Volatility 71.74% ( +12.68%)
  • Historical Volatility 47.49%
  • IV Percentile 99%
  • IV Rank 100.00%
  • IV High 71.74% on 04/10/25
  • IV Low 20.82% on 11/13/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 6,231
  • Volume Avg (30-Day) 3,062
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 119,668
  • Open Int (30-Day) 108,674

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.52
  • Number of Estimates 3
  • High Estimate 0.56
  • Low Estimate 0.49
  • Prior Year 0.67
  • Growth Rate Est. (year over year) -22.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.85 +3.05%
on 04/10/25
Period Open: 9.50
9.70 -27.22%
on 03/19/25
-2.44 (-25.68%)
since 03/10/25
3-Month
6.85 +3.05%
on 04/10/25
Period Open: 11.67
12.02 -41.26%
on 01/14/25
-4.61 (-39.50%)
since 01/10/25
52-Week
6.85 +3.05%
on 04/10/25
Period Open: 11.71
13.55 -47.90%
on 11/25/24
-4.65 (-39.71%)
since 04/10/24

Most Recent Stories

More News
3 Beaten-Down Stocks That Are Trading Below Their Book Values

A company's book value is equal to its total assets, less its liabilities. Book value does not consider the future at all. It is strictly a measure of the company's balance sheet values at any given time....

JBLU : 3.76 (-12.35%)
VTRS : 7.11 (-8.73%)
PLUG : 1.1150 (-7.85%)
PFE : 21.50 (-4.40%)
How Is Viatris’ Stock Performance Compared to Other Biotech Stocks?

Over the past six months, Viatris has lagged behind its biotech peers, and Wall Street analysts continue to exercise caution regarding the stock's future outlook.

VTRS : 7.11 (-8.73%)
IBBQ : 18.59 (-4.96%)
PRGO : 24.15 (-6.65%)
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

ELAN : 8.42 (-10.23%)
JAZZ : 102.38 (-7.03%)
VTRS : 7.11 (-8.73%)
ZTS : 145.34 (-5.35%)
ANIP : 64.67 (-2.03%)
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

VTRS : 7.11 (-8.73%)
AMPH : 23.28 (-7.73%)
ANIP : 64.67 (-2.03%)
AMRX : 6.98 (-6.06%)
1 Healthcare Stock to Target This Week and 2 to Turn Down

1 Healthcare Stock to Target This Week and 2 to Turn Down

PACB : 1.4100 (-2.76%)
VTRS : 7.11 (-8.73%)
BMRN : 56.20 (-5.43%)
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

VTRS : 7.11 (-8.73%)
ANIP : 64.67 (-2.03%)
AMPH : 23.28 (-7.73%)
AMRX : 6.98 (-6.06%)
Chip Stock Weakness and Tariff Angst Sink Stocks

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -1.59%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.45% and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.75%. March E-mini...

AMAT : 136.77 (-8.66%)
AXON : 552.41 (-1.33%)
$IUXX : 18,346.07 (-4.17%)
UNH : 597.34 (+3.26%)
ELV : 438.48 (+0.64%)
ZNM25 : 110-230 (+0.35%)
PSTG : 42.02 (-6.00%)
ESM25 : 5,318.00 (-3.15%)
PZZA : 32.35 (-4.46%)
GFS : 33.61 (-7.10%)
VTRS : 7.11 (-8.73%)
WBA : 10.74 (-0.37%)
Why Viatris (VTRS) Shares Are Falling Today

Why Viatris (VTRS) Shares Are Falling Today

VTRS : 7.11 (-8.73%)
Nasdaq Slumps on Nvidia Weakness as Tariff Anxieties Loom Large

The S&P 500 Index ($SPX ) (SPY ) today is down -1.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.35%. March E-mini S&P futures...

AMAT : 136.77 (-8.66%)
AXON : 552.41 (-1.33%)
$IUXX : 18,346.07 (-4.17%)
ELV : 438.48 (+0.64%)
ZNM25 : 110-230 (+0.35%)
PSTG : 42.02 (-6.00%)
ESM25 : 5,318.00 (-3.15%)
PZZA : 32.35 (-4.46%)
GFS : 33.61 (-7.10%)
WBA : 10.74 (-0.37%)
VTRS : 7.11 (-8.73%)
WBD : 8.03 (-13.28%)
Viatris Misses Estimates, Cash Flow Up

Viatris reported mixed results for Q4 2024, missing revenue and EPS expectations, despite noteworthy debt reduction and portfolio adjustments.

VTRS : 7.11 (-8.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor...

See More

Key Turning Points

3rd Resistance Point 8.92
2nd Resistance Point 8.39
1st Resistance Point 8.09
Last Price 7.11
1st Support Level 7.26
2nd Support Level 6.73
3rd Support Level 6.43

See More

52-Week High 13.55
Fibonacci 61.8% 10.99
Fibonacci 50% 10.20
Fibonacci 38.2% 9.41
Last Price 7.11
52-Week Low 6.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar